Lawrence S. Phillips mostly deals with Internal medicine, Diabetes mellitus, Endocrinology, Randomized controlled trial and Insulin. His work deals with themes such as Placebo and Surgery, which intersect with Internal medicine. His Diabetes mellitus research is mostly focused on the topic Type 2 diabetes.
His Endocrinology study incorporates themes from Gastroenterology and Chemotherapy. His study in Insulin is interdisciplinary in nature, drawing from both Ketoacidosis and Obesity. His Women's Health Initiative research is multidisciplinary, relying on both Incidence, Gynecology, Hazard ratio, Physical therapy and Hormone replacement therapy.
Lawrence S. Phillips spends much of his time researching Internal medicine, Diabetes mellitus, Endocrinology, Type 2 diabetes and Insulin. As part of his studies on Internal medicine, Lawrence S. Phillips often connects relevant subjects like Surgery. His work carried out in the field of Diabetes mellitus brings together such families of science as Body mass index and Incidence.
His Endocrinology research incorporates themes from Growth factor and Insulin-like growth factor. His biological study spans a wide range of topics, including Hypoglycemia, Psychological intervention, Vitamin D and neurology, Pediatrics and Cohort. His research in Women's Health Initiative focuses on subjects like Hazard ratio, which are connected to Proportional hazards model and Overweight.
Lawrence S. Phillips mostly deals with Diabetes mellitus, Internal medicine, Type 2 diabetes, Prediabetes and Veterans Affairs. His studies deal with areas such as Hemoglobin, Clinical trial, Incidence, Population study and Waist as well as Diabetes mellitus. As part of the same scientific family, Lawrence S. Phillips usually focuses on Internal medicine, concentrating on Endocrinology and intersecting with Chromosome.
His Type 2 diabetes research is multidisciplinary, incorporating perspectives in Odds ratio, Vitamin D and neurology, Postprandial and Glycemic. His Prediabetes study integrates concerns from other disciplines, such as Impaired glucose tolerance, Glucose Measurement, Overdiagnosis, National Health and Nutrition Examination Survey and Glucose challenge test. His work deals with themes such as Regimen, Chronic condition, Focus group and Comorbidity, which intersect with Veterans Affairs.
Lawrence S. Phillips mainly focuses on Diabetes mellitus, Prediabetes, Internal medicine, Type 2 diabetes and Waist. His research on Diabetes mellitus frequently connects to adjacent areas such as Prospective cohort study. His Prediabetes research also works with subjects such as
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Surgery and Population study. His biological study spans a wide range of topics, including Incidence and Women's Health Initiative. His study in Incidence is interdisciplinary in nature, drawing from both Anthropometry, Ethnic group, Physical therapy and Confounding.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson;Marian C. Limacher;Annlouise R. Assaf;Tamsen Bassford.
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.
R. N. Bergman;L. S. Phillips;Claudio Cobelli.
Journal of Clinical Investigation (1981)
Calcium plus vitamin D supplementation and the risk of fractures.
Rebecca D. Jackson;Andrea Z. LaCroix;Margery Gass;Robert B. Wallace.
The New England Journal of Medicine (2006)
Low-fat dietary pattern and risk of cardiovascular disease : The women's health initiative randomized controlled dietary modification trial
Barbara V. Howard;Barbara V. Howard;Linda Van Horn;Judith Hsia;JoAnn E. Manson.
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Jean Wactawski-Wende;Jane Morley Kotchen;Garnet L. Anderson;Annlouise R. Assaf;Annlouise R. Assaf.
The New England Journal of Medicine (2006)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer Pj;Drake Wm;Katznelson L;Freda Pu.
The New England Journal of Medicine (2000)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino.
Relationship of depression to diabetes types 1 and 2: Epidemiology, biology, and treatment
Dominique L Musselman;Ephi Betan;Hannah Larsen;Lawrence S Phillips.
Biological Psychiatry (2003)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Aart Jan van der Lely;R Kent Hutson;Peter J Trainer;G Michael Besser.
The Lancet (2001)
Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Shirley A. A. Beresford;Karen C. Johnson;Cheryl Ritenbaugh;Norman L. Lasser.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: